Anti-atherosclerotic effects of vitamin E - Myth or reality?

Journal of Cellular and Molecular Medicine

Volumn 8, Issue 1, 2004, Pages 59-76

  Munteanu, Adelina ^a   Zingg, J M ^a   Azzi, Angelo ^a,b  

^a UNIVERSITY OF BERN   (Switzerland)

^b Institute of Biochemistry and Molecular Biology   (Switzerland)

Author keywords

Atherosclerosis; Clinical trials; Gene expression; Non antioxidant; Signalling; Tocopherol binding proteins; Transcription factors; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARACHIDONATE 5 LIPOXYGENASE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; MEMBRANE PROTEIN; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C; PTGS2 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE;

ADULT; AGED; ANIMAL; APOPTOSIS; ARTERIOSCLEROSIS; BIOLOGICAL MODEL; CELL ADHESION; CLINICAL TRIAL; DISEASE MODEL; DRUG ANTAGONISM; FEMALE; GENETIC TRANSCRIPTION; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ADULT; AGED; ALPHA-TOCOPHEROL; ANIMALS; ANTIOXIDANTS; APOPTOSIS; ARACHIDONATE 5-LIPOXYGENASE; ARTERIOSCLEROSIS; BIOLOGICAL TRANSPORT; CELL ADHESION; CLINICAL TRIALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, BIOLOGICAL; NITRIC OXIDE SYNTHASE; PHOSPHOPROTEIN PHOSPHATASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEIN KINASE C; SUPEROXIDE DISMUTASE; TRANSCRIPTION, GENETIC; VITAMIN E;

EID: 3142667617     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2004.tb00260.x     Document Type: Review

References (126)

1. Vogelsang A., Shute, E.V., Effect of vitamin E in coronary heart disease., Nature, 157: 772, 1946
2. Ricciarelli R., Zingg J.M., Azzi, A., Vitamin E: protective role of a Janus molecule, FASEB. J., 15: 2314-2325, 2001
3. Brigellus-Flohe R., Kelly F.J., Salonen J.T., Neuzil J., Zingg J.M., Azzi A., The European perspective on vitamin E: current knowledge and future research, Am. J. Clin. Nutr., 76: 703-716, 2002
4. Rimbach G., Minihane A.M., Majewicz J., Fischer A., Pallauf J., Virgli F., Weinberg P.D., Regulation of cell signalling by vitamin E, Proc. Nutr. Soc, 61: 415-425, 2002
5. Bauernfeind J.B., Tocopherols in Food. Vitamin E. A Comprehensive Treatise., Marcel Dekker, I., New York and Basel, Ed., 1980, pp. 99-167.
6. Birringer M., EyTina J.H., Salvatore B.A., Neuzil J., Vitamin E analogues as inducers of apoptosis: structure-function relation, Br. J. Cancer, 88: 1948-1955, 2003
7. Burton G.W., Traber M.G., Vitamin E: antioxidant activity, biokinetics, and bioavailability, Annu. Rev. Nutr., 10: 357-382, 1990
8. Catignani G.L., Bieri J.G., Rat liver alpha-tocopherol binding protein, Biochim Biophys Acta, 497: 349-357, 1977
9. Hosomi A., Arita M., Sato Y., Kiyose C., Ueda T., Igarashi O., Arai H., Inoue K., Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs, FEBS. Lett., 409: 105-108, 1997
10. Kostner G.M., Oettl K., Jauhiainen M., Ehnholm C., Esterbauer H., Dieplinger H., Human plasma phospholipid transfer protein accelerates exchange/transfer of alpha-tocopherol between lipoproteins and cells, Biochem. J., 305: 659-667, 1995
11. Goti D., Reicher H., Malle E., Kostner G.M., Panzenboeck U., Sattler W., High-density lipoprotein (HDL3)-associated alpha-tocopherol is taken up by HepG2 cells via the selective uptake pathway and resecreted with endogenously synthesized apo-lipoprotein B-rich lipoprotein particles, Biochem. J., 332: 57-65, 1998
12. Fechner H., Schlame M., Guthmann F., Stevens P.A. Rustow B., alpha- and delta-tocopherol induce expression of hepatic alpha-tocopherol-transfer-protein mRNA, Biochem. J., 331: 577-581, 1998
13. Yokota T., Shiojiri T., Gotoda T., Arita M., Arai H., Ohga T., Kanda T., Suzuki J., Imai T., Matsumoto H., Harino S., Kiyosawa M., Mizusawa H., Inoue, K., Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene, Ann. Neurol., 41: 826-832, 1997
14. Terasawa Y., Ladha Z., Leonard S.W., Morrow J.D., Newland D., Sanan D., Packer L., Traber M.G., Farese R.V., Jr., Increased atherosclerosis in hyperlipidemic mice deficient in alpha - tocopherol transfer protein and vitamin E, Proc. Natl. Acad. Sco. U.S.A., 97: 13830-13834, 2000
15. Roxborough H.E., Burton G.W., Kelly, F.J., Inter- and intra-individual variation in plasma and red blood cell vitamin E after supplementation, Free Radic Res, 33: 437-445, 2000
16. Drevon C.A., Absorption, transport and metabolism of vitamin E, Free. Radic. Res. Commun., 14: 229-246, 1991
17. Copp R.P., Wisniewski T., Hentati F., Larnaout A., Ben Hamida M., Kayden H.J., Localization of alpha-tocopherol transfer protein in the brains of patients with ataxia with vitamin E deficiency and other oxidative stress related neurodegenerative disorders, Brain Res., 822: 80-87, 1999
18. Tamaru Y., Hiran, M., Kusaka, H., Ito H., Imai T., Ueno S., alpha-Tocopherol transfer protein gene: exon skipping of all transcripts causes ataxia, Neurology, 49: 584-588, 1997
19. Kempnà P., Zingg J.M., Ricciarelli R., Hierl M., Saxena S. Azzi A., Cloning of novel human SEC14p-like proteins: cellular localization, ligand binding and functional properties, Free Radic. Biol. Med., 34, 1458-1472, 2003
20. Dutta-Roy A.K., Leishman D.J., Gordon M.J., Campbell F.M., Duthie G.G., Identification of a low molecular mass (14.2 kDa) alpha-tocopherol- binding protein in the cytosol of rat liver and heart, Biochem. Biophys. Res. Commun., 196: 1108-1112, 1993
21. Simon E.J., The metabolism of vitamin E. II. Purification and characterization of urinary metabolites of alpha-tocopherol., J. Biol. Chem., 221: 807-817, 1956
22. Simon E.J., Gross C.S., Milhorat, A.T., The metabolism of vitamin E. The absorption and excretion of d-α-tocopheryl-5-methyl-C14-succinate., J. Biol. Chem., 221: 797-805, 1956
23. Schultz M., Leist M., Petrzika M., Gassmann B., Brigelius-Flohe R., Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2′- carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply?, Am. J. Clin. Nutr., 62: 1527S-1534S, 1995
24. Chiku S., Hamamura K., Nakamura T., Novel urinary metabolite of d-delta-tocopherol in rats, J. Lipid. Res., 25: 40-48, 1984
25. Wechter W.J., Kantoci D., Murray E.D., Jr., D'Amico, D.C., Jung, M.E., Wang, W.H., A new endogenous natriuretic factor: LLU-alpha, Proc. Natl. Acad. Sci. U.S.A., 93: 6002-6007, 1996
26. Himmelfarb J., Kane J., McMonagle E., Zaltas E., Bobzin S., Boddupalli S., Phinney S., Miller, G., Alpha and gamma tocopherol metabolism in healthy subjects and patients with end-stage renal disease, Kidney Int., 64: 978-991, 2003
27. Murray E.D., Jr., Wechter W.J., Kantoci D., Wang W.H., Pham T., Quiggle D.D., Gibson K.M., Leipold, D., Anner, B.M., Endogenous natriuretic factors 7: biospecificity of a natriuretic gamma-tocopherol metabolite LLU-alpha, J. Pharmacol. Exp. Ther., 282: 657-662, 1997
28. Jiang Q., Christen S., Shigenaga M.K., Ames B.N., gamma-Tocopherol, the major form of vitamin E in the US diet, deserves more attention, Am. J. Clin. Nutr., 74: 714-722, 2001
29. Jiang Q., Elson-Schwab I., Courtemanche C., Ames, B.N., gamma-Tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells, Proc. Natl. Acad. Sci. U.S.A., 97: 11494-11499, 2000
30. Schwenke D.C., Rudel L.L., Sorci-Thomas M.G., Thomas M.J., alpha-Tocopherol protects against diet induced atherosclerosis in New Zealand white rabbits, J. Lipid Res., 43: 1927-1938, 2002
31. Peluzio M.C., Homem A.P., Cesar G.C., Azevedo G.S., Amorim R., Cara D.C., Saliba H., Vieira E.C., Arantes R.E., Alvarez-Leite J., Influences of alpha-tocopherol on cholesterol metabolism and fatty streak development in apolipoprotein E-deficient mice fed an atherogenic diet, Braz. J. Med. Biol. Res., 34: 1539-1545, 2001
32. Peluzio M.C., Miguel E., Jr., Drumond T.C., Cesar G.C., Santiago H.C., Teixeira M.M., Vieira E.C., Arantes R.M., Alvarez-Leite, J.I., Monocyte chemoattractant protein-1 involvement in the alpha-tocopherol-induced reduction of atherosclerotic lesions in apolipoprotein E knockout mice, Br. J. Nutr., 90: 3-11, 2003
33. Verlangieri A.J., Bush M.J., Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis, J. Am. Coll. Nutr., 11: 131-138, 1992
34. Upston J.M., Terentis A.C., Stocker, R., Tocopherol-mediated peroxidation of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement, FASEB. J., 13: 977-994, 1999
35. Gohil K., Schock B.C., Chakraborty A.A., Terasawa Y., Raber J., Farese R.V., Jr., Packer L., Cross C.E., Traber, M.G., Gene expression profile of oxidant stress and neurodegeneration in transgenic mice deficient in alpha-tocopherol transfer protein, Free Radic Biol Med, 35: 1343-1354, 2003
36. Rapola J.M., Virtamo J., Haukka J.K., Heinonen O.P., Albanes D., Taylor P.R., Huttunen J.K., Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial, JAMA, 275: 693-698, 1996
37. de Gaetano G., Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project, Lancet, 357: 89-95, 2001
38. Salonen J.T., Nyyssonen K., Salonen R., Lakka H.M., Kaikkonen J., Porkkala-Sarataho E., Voutilainen S., Lakka T.A., Rissanen T., Leskinen L., Tuomainen T.P., Valkonen V.P., Ristonmaa U., Poulsen H.E., Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis, J. Intern. Med., 248: 377-386, 2000
39. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J., Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS), Lancet, 347: 781-786, 1996
40. Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green, M.S., Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial, Lancet, 356: 1213-1218, 2000
41. Marchioli R., Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico, Lancet, 354: 447-455, 1999
42. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P., Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators, N. Engl. J. Med., 342: 154-160, 2000
43. Ehnholm C., Tenkanen H., de Knijff P., Havekes L., Rosseneu M., Menzel H.J., Tiret L., Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. European Atherosclerosis Research Study, Atherosclerosis, 107: 229-238, 1994
44. Morris B.J., Glenn C.L., Wilcken D.E., Wang X.L., Influence of an inducible nitric oxide synthase promoter variant on clinical variables in patients with coronary artery disease, Clin Sci (Lond), 100: 551-556, 2001
45. Tang Y., Taylor K.T., Sobieski D.A., Medved E.S., Lipsky R.H., Identification of a human CD36 isoform produced by exon skipping. Conservation of exon organization and pre-mRNA splicing patterns with a CD36 gene family member, CLA-1, J. Biol. Chem., 269: 6011-6015, 1994
46. Kern P., Kolowos W., Hagenhofer M., Frank C., Kalden J.R., Herrmann M., Alternatively spliced mRNA molecules of the thrombospondin receptor (CD36) in human PBMC, Eur. J. Immunogenet., 26: 337-342, 1999
47. Fang J.C., Kinlay S., Beltrame J., Hikiti H., Wainstein, M., Behrendt D., Suh J., Frei B., Mudge G.H., Selwyn A.P., Ganz P., Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial, Lancet, 359: 1108-1113, 2002
48. Vivekananthan D.P., Penn M.S., Sapp S.K., Hsu A., Topol E.J., Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials, Lancet, 361: 2017-2023, 2003
49. Meagher E.A., Barry O.P., Lawson J.A., Rokach J., FitzGerald G.A., Effects of vitamin E on lipid peroxidation in healthy persons, JAMA, 285: 1178-1182, 2001
50. Traber M.G., Elsner A., Brigelius-Flohe R., Synthetic as compared with natural vitamin E is preferentially excreted as alpha-CEHC in human urine: studies using deuterated alpha-tocopheryl acetates, FEBS Lett., 437: 145-148, 1998
51. Burton G.W., Traber M.G., Acuff R.V., Walters D.N., Kayden H., Hughes L., Ingold K.U., Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E, Am. J. Clin. Nutr., 67: 669-684, 1998
52. Mitchinson M.J., Macrophages, oxidised lipids and atherosclerosis, Med. Hypotheses, 12: 171-178, 1983
53. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum, J.L., Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity, N Engl J Med, 320: 915-924, 1989
54. Ross R., The pathogenesis of atherosclerosis: a perspective for the 1990s, Nature, 362: 801-809, 1993
55. Stocke R., The ambivalence of vitamin E in atherogenesis, Trends Biochem. Sci., 24: 219-223, 1999
56. Cachia O., Leger C.L., Descomps B., Monocyte superoxide production is inversely related to normal content of alpha-tocopherol in low-density lipoprotein, Atherosclerosis, 138: 263-269, 1998
57. Keaney J.F., Jr., Atherosclerosis: from lesion formation to plaque activation and endothelial dysfunction, Mol Aspects Med, 21: 99-166, 2000
58. Serbinova E., Kagan V., Han D., Packer L., Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol, Free Radic Biol Med, 10: 263-275, 1991
59. Suzuki Y.J., Packer, L., Inhibition of NF-kappa B activation by vitamin E derivatives, Biochem Biophys Res Commun, 193: 277-283, 1993
60. Wolf G., gamma-Tocopherol: an efficient protector of lipids against nitric oxide- initiated peroxidative damage, Nutr. Rev., 55: 376-378, 1997
61. Goss S.P., Hogg N., Kalyanaraman B., The effect of alpha-tocopherol on the nitration of gamma-tocopherol by peroxynitrite, Arch. Biochem. Biophys., 363: 333-340, 1999
62. Boscoboinik D., Szewczyk A., Hensey C., Azzi A., Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C, J. Biol. Chem., 266: 6188-6194, 1991
63. Tasinato A., Boscoboinik D., Bartoli G.M., Maroni P., Azzi A., d-alpha-tocopherol inhibition of vascular smooth muscle cell proliferation occurs at physiological concentrations, correlates with protein kinase C inhibition, and is independent of its antioxidant properties, Proc. Natl. Acad. Sci. U.S.A., 92: 12190-12194, 1995
64. Devaraj S., Li D., Jialal I., The effects of alpha tocopherol supplementation on monocyte function. Decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium, J. Clin. Invest., 98: 756-763, 1996
65. Devaraj S., Adams-Huet B., Fuller C.J., Jialal I., Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation, Arterioscler. Thromb. Vasc. Biol., 17: 2273-2279, 1997
66. Freedman J.E., Farhat J.H., Loscalzo J., Keaney, J.F., Jr., Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism, Circulation, 94: 2434-2440, 1996
67. Tada H., Ishii H., Isogai S., Protective effect of D-alpha-tocopherol on the function of human mesangial cells exposed to high glucose concentrations, Metabolism, 46: 779-784, 1997
68. Martin-Nizard F., Boullier A., Fruchart J.C., Duriez, P., Alpha-tocopherol but not beta-tocopherol inhibits thrombin-induced PKC activation and endothelin secretion in endothelial cells, J. Cardiovasc. Risk, 5: 339-345, 1998
69. Cachia O., Benna J.E., Pedruzzi E., Descomps B., Gougerot-Pocidalo, M.A., Leger, C.L., alpha-tocopherol inhibits the respiratory burst in human monocytes. Attenuation of p47(phox) membrane translocation and phosphorylation, J. Biol. Chem., 273: 32801-32805, 1998
70. Williams J.C., Forster L.A., Tull S.P., Wong M., Bevan R.J., Ferns G.A., Dietary vitamin E supplementation inhibits thrombin-induced platelet aggregation, but not monocyte adhesiveness, in patients with hypercholesterolaemia, Int. J. Exp. Pathol, 78: 259-266, 1997
71. Saldeen T., Li D., Mehta J.L., Differential effects of alpha- and gamma-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis, J. Am. Coll. Cardiol., 34: 1208-1215, 1999
72. Mabile L., Bruckdorfer K.R., Rice-Evans C., Moderate supplementation with natural alpha-tocopherol decreases platelet aggregation and low-density lipoprotein oxidation, Atherosclerosis, 147: 177-185, 1999
73. Ricciarelli R., Azzi A., Regulation of recombinant PKC alpha activity by protein phosphatase 1 and protein phosphatase 2A, Arch. Biochem. Biophys., 355: 197-200, 1998
74. Ricciarelli R., Tasinato A., Clement S., Ozer N.K., Boscoboinik D., Azzi A., alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state, Biochem. J., 334: 243-249, 1998
75. Clement S., Tasinato A., Boscoboinik D., Azzi A., The effect of alpha-tocopherol on the synthesis, phosphorylation and activity of protein kinase C in smooth muscle cells after phorbol 12- myristate 13-acetate down-regulation, Eur. J. Biochem., 246: 745-749, 1997
76. Jiang Q., Ames B.N., gamma-Tocopherol, but not alpha-tocopherol, decreases proinflammatory eicosanoids and inflammation damage in rats, FASEB J., 17: 816-822, 2003
77. Wu D.Y., Hayek M.G., Meydani S.N., Vitamin E and macrophage cyclooxygenase regulation in the aged, J. Nutr., 131: 382S-388S, 2001
78. Devaraj S., Jialal I., Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase, Arterioscler. Thromb. Vasc. Biol., 19: 1125-1133, 1999
79. Poynter M.E., Daynes R.A., Age-associated alterations in splenic iNOS regulation: influence of constitutively expressed IFN-gamma and correction following supplementation with PPARalpha activators or vitamin E, Cell Immunol., 195: 127-136, 1999
80. Li D., Saldeen T., Romeo F., Mehta J.L., Relative Effects of alpha- and gamma-Tocopherol on Low-Density Lipoprotein Oxidation and Superoxide Dismutase and Nitric Oxide Synthase Activity and Protein Expression in Rats, J. Cardiovasc. Pharmacol. Ther., 4: 219-226, 1999
81. Lindner V., Collins T., Expression of NF-kappa B and I kappa B-alpha by aortic endothelium in an arterial injury model, Am. J. Pathol., 148: 427-438, 1996
82. Liao F., Andalibi A., deBeer F.C., Fogelman A.M., Lusis A.J., Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice, J. Clin. Invest., 91: 2572-2579, 1993
83. Yan S.D., Schmidt A.M., Anderson G.M., Zhang J., Brett J., Zou Y.S., Pinsky D., Stern D., Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J. Biol. Chem., 269: 9889-9897, 1994
84. Rimbach G., Valacchi G., Canali R., Virgili F., Macrophages stimulated with IFN-gamma activate NF-kappa B and induce MCP-1 gene expression in primary human endothelial cells, Mol. Cell. Biol. Res. Commun., 3: 238-242, 2000
85. Collins T., Cybulsky M.I., NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?, J. Clin. Invest., 107: 255-264, 2001
86. Stauble, B., Boscoboinik, D., Tasinato, A., Azzi, A., Modulation of activator protein-1 (AP-1) transcription factor and protein kinase C by hydrogen peroxide and D-alpha-tocopherol in vascular smooth muscle cells, Eur. J. Biochem., 226: 393-402, 1994
87. Poynter, M.E., Daynes, R.A., Peroxisome proliferator-activated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging, J. Biol. Chem., 273: 32833-32841, 1998
88. Landes N., Pfluger P., Kluth D., Birringer M., Ruhl R., Bol G.F., Glatt H., Brigelius-Flohe R., Vitamin E activates gene expression via the pregnane X receptor, Biochem. Pharmacol., 65: 269-273, 2003
89. Yoshida N., Manabe H., Terasawa Y., Nishimura H., Enjo F., Nishino H., Yoshikawa T., Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein, Biofactors, 13: 279-288, 2000
90. Islam K.N., Devaraj S., Jialal I., alpha-Tocopherol enrichment of monocytes decreases agonist-induced adhesion to human endothelial cells, Circulation, 98: 2255-2261, 1998
91. Martin G., Schoonjans K., Lefebvre A.M., Staels B., Auwerx J., Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators, J. Biol. Chem., 272: 28210-28217, 1997
92. Yoshida N., Yoshikawa T., Manabe H., Terasawa Y., Kondo M., Noguchi N., Niki E., Vitamin E protects against polymorphonuclear leukocyte-dependent adhesion to endothelial cells, J. Leukoc. Biol., 65: 757-763, 1999
93. Wu D., Koga T., Martin K.R., Meydani M., Effect of vitamin E on human aortic endothelial cell production of chemokines and adhesion to monocytes, Atherosclerosis, 147: 297-307, 1999
94. Yoshikawa T., Yoshida N., Manabe H., Terasawa Y., Takemura T., Kondo M., alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells, Biofactors, 7: 15-19, 1998
95. Steiner M., Li W., Ciaramella J.M., Anagnostou A., Sigounas, G., dl-alpha-tocopherol, a potent inhibitor of phorbol ester induced shape change of erythro- and megakaryoblastic leukemia cells, J. Cell. Physiol, 172: 351-360, 1997
96. de Nigris F., Franconi F., Maida I., Palumbo G., Anania V., Napoli C., Modulation by alpha- and gamma-tocopherol and oxidized low-density lipoprotein of apoptotic signaling in human coronary smooth muscle cells, Biochem Pharmacol, 59: 1477-1487, 2000
97. Lyons N.M., Woods J.A., O'Brien N.M., alpha-Tocopherol, but not gamma-tocopherol inhibits 7 beta-hydroxycholesterol-induced apoptosis in human U937 cells, Free Radic Res, 35: 329-339, 2001
98. Azzi A., Boscoboinik D., Fazzio A., Marilley D., Maroni P., Ozer N.K., Spycher, S., Tasinato, A., RRR-alpha-tocopherol regulation of gene transcription in response to the cell oxidant status, Z. Ernahrungswiss., 37 Suppl 1, 21-28, 1998
99. Azzi A., Gysin R., Kempna P., Ricciarelli R., Villacorta L., Visarius T., Zingg J.M., Regulation of Gene and Protein Expression by Vitamin E, Free Radic. Res., 36: 30-35, 2002
100. Ricciarelli R., Zingg J.M., Azzi A., Vitamin E reduces the uptake of oxidized LDL by inhibiting CD36 scavenger receptor expression in cultured human aortic smooth muscle cells, Circulation, 102: 82-87, 2000
101. Teupser D., Thiery J., Seidel D., Alpha-tocopherol down-regulates scavenger receptor activity in macrophages, Atherosclerosis, 144: 109-115, 1999
102. Devaraj, S., Hugou, I., Jialal, I., Alpha-tocopherol decreases CD36 expression in human monocyte-derived macrophages, J. Lipid. Res., 42: 521-527, 2001
103. Febbraio M., Podrez E.A., Smith J.D., Hajjar D.P., Hazen S.L., Hoff H.F., Sharma K., Silverstein R.L., Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice, J. Clin. Invest., 105: 1049-1056, 2000
104. Fuhrman B., Volkova N., Aviram M., Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice: protective role of antioxidants and of paraoxonase, Atherosclerosis, 161: 307-316, 2002
105. Marui N., Offermann M.K., Swerlick R., Kunsch C., Rosen C.A., Ahmad M., Alexander R.W., Medford R.M., Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells, J. Clin. Invest., 92: 1866-1874, 1993
106. Zapolska-Downar D., Zapolski-Downar A., Markiewski M., Ciechanowicz A., Kaczmarczyk M., Naruszewicz M., Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells, Biochem. Biophys. Res. Commun., 274: 609-615, 2000
107. Sabat, R., Kolleck, I., Witt, W., Volk, H., Sinha, P., Rustow, B., Immunological dysregulation of lung cells in response to vitamin E deficiency, Free Radic Biol Med, 30: 1145-1153, 2001
108. Terasawa Y., Manabe H., Yoshida N., Uemura M., Sugimoto N., Naito Y., Yoshikawa T., Kondo M., Alpha-tocopherol protects against monocyte Mac-1 (CD11b/CD18) expression and Mac-1-dependent adhesion to endothelial cells induced by oxidized low-density lipoprotein, Biofactors, 11: 221-233, 2000
109. Kim H.S., Arai H., Arita M., Sato Y., Ogihara T., Inoue K., Mino M., Tamai, H., Effect of alpha-tocopherol status on alpha-tocopherol transfer protein expression and its messenger RNA level in rat liver, Free Radic. Res., 28: 87-92, 1998
110. Kolleck, I., Schlame, M., Fechner, H., Looman, A.C., Wissel, H., Rustow, B., HDL is the major source of vitamin E for type II pneumocytes, Free Radic. Biol. Med., 27: 882-890, 1999
111. Teupser D., Thiery J., Seidel, D., Alpha-tocopherol down-regulates scavenger receptor activity in macrophages, Atherosclerosis, 144: 109-115, 1999
112. Ikeda M., Schroeder K.K., Mosher L.B., Woods C.W., Akeson A.L., Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes, J. Invest. Dermatol., 103: 791-796, 1994
113. Desideri G., Croce G., Marinucci M.C., Masci P.G., Stati M., Valeri L., Santucci A., Ferri C., Prolonged, low dose alpha-tocopherol therapy counteracts intercellular cell adhesion molecule-1 activation, Clin. Chim. Acta, 320: 5-9, 2002
114. Breyer I., Azzi A., Differential inhibition by alpha- and beta-tocopherol of human erythroleukemia cell adhesion: role of integrins, Free Radic. Biol. Med., 30: 1381-1389, 2001
115. Faruqi R., de la Motte, C., Di Corleto P.E., Alpha-tocopherol inhibits agonist-induced monocytic cell adhesion to cultured human endothelial cells, J. Clin. Invest., 94: 592-600, 1994
116. Chang S.J., Lin J.S., Chen H.H., Alpha-tocopherol downregulates the expression of GPIIb promoter in HEL cells, Free Radic. Biol. Med., 28: 202-207, 2000
117. Villacorta L., Graca-Souza, A.V., Ricciarelli, R., Zingg, J.M., Azzi A., Alpha-Tocopherol Induces Expression of Connective Tissue Growth Factor and Antagonizes Tumor Necrosis Factor-Alpha-Mediated Downregulation in Human Smooth Muscle Cells, Circ. Res., 92, 104-110, 2003
118. Li-Weber M., Giaisi M., Treiber M.K., Krammer P.H., Vitamin E inhibits IL-4 gene expression in peripheral blood T cells, Eur. J. Immunol., 32: 2401-2408, 2002
119. Akeson A.L., Schroeder K., Woods C., Schmidt C.J., Jones W.D., Suppression of interleukin-1 beta and LDL scavenger receptor expression in macrophages by a selective protein kinase C inhibitor, J. Lipid Res., 32: 1699-1707, 1991
120. Parola M., Muraca R., Dianzani I., Barrera G., Leonarduzzi G., Bendinelli P., Piccoletti R., Poli G., Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver, FEBS Lett., 308: 267-270, 1992
121. Venkateswaran V., Fleshner N.E., Klotz L.H., Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines, J. Urol, 168: 1578-1582, 2002
122. Gysin R., Azzi A., Visarius T., Gamma-tocopherol inhibits human cancer cell cycle progression and cell proliferation by down-regulation of cyclins, FASEB. J., 16: 1952-1954, 2002
123. Li-Weber M., Weigand M.A., Giaisi M., Suss D., Treiber M.K., Baumann S., Ritsou E., Breitkreutz R., Krammer P.H., Vitamin E inhibits CD95 ligand expression and protects T cells from activation-induced cell death, J. Clin. Invest., 110: 681-690, 2002
124. Fischer A., Pallauf J., Gohil K., Weber S.U., Packer L., Rimbach G., Effect of selenium and vitamin E deficiency on differential gene expression in rat liver, Biochem. Biophys. Res. Commun., 285: 470-475, 2001
125. Campbell S.E., Stone W.L., Whaley S.G., Qui M., Krishnan K., Gamma (gamma) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (gamma) expression in SW 480 human colon cancer cell lines, BMC Cancer, 3: 25, 2003
126. Pal S., Thomson A.M., Bottema C.D., Roach P.D., alpha-Tocopherol modulates the low density lipoprotein receptor of human HepG2 cells, Nutr J., 2: 3, 2003